Prestige Wealth Management Group LLC trimmed its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 95.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 445 shares of the company’s stock after selling 10,091 shares during the period. Prestige Wealth Management Group LLC’s holdings in Corteva were worth $37,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the company. JPL Wealth Management LLC purchased a new stake in Corteva during the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva during the 4th quarter worth $27,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva during the 4th quarter worth $28,000. Cornerstone Financial Management LLC bought a new stake in shares of Corteva during the 4th quarter valued at $29,000. Finally, Basepoint Wealth LLC purchased a new stake in shares of Corteva in the 4th quarter worth $30,000. 81.54% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on CTVA. Argus raised their target price on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Rothschild & Co Redburn upped their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Citigroup raised their price objective on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Bank of America lifted their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday. Finally, Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.19.
Corteva Trading Up 0.2%
Shares of CTVA stock opened at $88.74 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a fifty day simple moving average of $81.25 and a two-hundred day simple moving average of $78.84. The firm has a market capitalization of $59.35 billion, a PE ratio of 52.20, a PEG ratio of 2.69 and a beta of 0.56. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $89.39.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.
Corteva Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s payout ratio is currently 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
